• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子通过形成受体、Grb2衔接蛋白和Sos核苷酸交换因子的复合物来调节p21ras。

Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor.

作者信息

Buday L, Downward J

机构信息

Signal Transduction Laboratory, Imperial Cancer Research Fund, Lincoln's Inn Fields, London, England.

出版信息

Cell. 1993 May 7;73(3):611-20. doi: 10.1016/0092-8674(93)90146-h.

DOI:10.1016/0092-8674(93)90146-h
PMID:8490966
Abstract

Antisera against murine Son of sevenless (Sos) recognize a protein of M(r) 155,000 in rat-1 fibroblasts with specific guanine nucleotide exchange activity toward p21c-Ha-ras. Epidermal growth factor (EGF) receptor coimmunoprecipitates with Sos from EGF-stimulated, but not quiescent, cells. The SH2 and SH3 domain-containing "adapter" protein Grb2 is also found in Sos immunoprecipitates in an EGF-inducible manner. In vitro reconstitution shows that Grb2 is required for the binding of activated EGF receptor to Sos. A phosphopeptide corresponding to tyrosine 1068 of the EGF receptor blocks both the assembly of the complex and EGF stimulation of nucleotide exchange on p21ras in a permeabilized cell system. These results suggest that EGF-induced activation of nucleotide exchange on p21ras proceeds through the recruitment of cytosolic Sos to a complex with EGF receptor and Grb2 at the plasma membrane.

摘要

抗小鼠七号less之子(Sos)的抗血清在大鼠-1成纤维细胞中识别出一种分子量为155,000的蛋白质,该蛋白质对p21c-Ha-ras具有特定的鸟嘌呤核苷酸交换活性。表皮生长因子(EGF)受体在EGF刺激而非静止的细胞中与Sos共同免疫沉淀。含SH2和SH3结构域的“衔接子”蛋白Grb2也以EGF诱导的方式存在于Sos免疫沉淀复合物中。体外重组实验表明,Grb2是活化的EGF受体与Sos结合所必需的。在通透细胞系统中,对应于EGF受体酪氨酸1068的磷酸肽可阻断复合物的组装以及EGF对p21ras核苷酸交换的刺激。这些结果表明,EGF诱导的p21ras核苷酸交换激活是通过将胞质Sos募集到质膜上与EGF受体和Grb2形成的复合物来实现的。

相似文献

1
Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor.表皮生长因子通过形成受体、Grb2衔接蛋白和Sos核苷酸交换因子的复合物来调节p21ras。
Cell. 1993 May 7;73(3):611-20. doi: 10.1016/0092-8674(93)90146-h.
2
Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras.Shc参与胰岛素和表皮生长因子诱导的p21ras激活。
Mol Cell Biol. 1994 Mar;14(3):1575-81. doi: 10.1128/mcb.14.3.1575-1581.1994.
3
Divergent mechanisms for homologous desensitization of p21ras by insulin and growth factors.胰岛素和生长因子对p21ras同源脱敏的不同机制。
J Biol Chem. 1995 Oct 6;270(40):23421-8. doi: 10.1074/jbc.270.40.23421.
4
SH3 domains of the adapter molecule Grb2 complex with two proteins in T cells: the guanine nucleotide exchange protein Sos and a 75-kDa protein that is a substrate for T cell antigen receptor-activated tyrosine kinases.衔接分子Grb2的SH3结构域与T细胞中的两种蛋白质结合:鸟嘌呤核苷酸交换蛋白Sos和一种75 kDa的蛋白质,该蛋白质是T细胞抗原受体激活的酪氨酸激酶的底物。
J Biol Chem. 1994 May 13;269(19):14081-7.
5
Disassembly of Son-of-sevenless proteins from Grb2 during p21ras desensitization by insulin.在胰岛素使p21ras脱敏过程中,七号less蛋白之子蛋白与Grb2的解离。
J Biol Chem. 1995 Jan 27;270(4):1485-8.
6
Independent binding of peptide ligands to the SH2 and SH3 domains of Grb2.肽配体与Grb2的SH2和SH3结构域的独立结合。
J Biol Chem. 1994 Dec 16;269(50):31653-8.
7
A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells.Grb2衔接蛋白、Sos交换因子和一种36 kDa膜结合酪氨酸磷酸蛋白的复合物与T细胞中的Ras激活有关。
J Biol Chem. 1994 Mar 25;269(12):9019-23.
8
Epidermal growth factor receptor targeting prevents uncoupling of the Grb2-SOS complex.表皮生长因子受体靶向作用可防止Grb2-SOS复合物解偶联。
J Biol Chem. 1996 Apr 5;271(14):8300-6. doi: 10.1074/jbc.271.14.8300.
9
Insulin and epidermal growth factor receptors regulate distinct pools of Grb2-SOS in the control of Ras activation.胰岛素和表皮生长因子受体在调控Ras激活过程中调节Grb2-SOS的不同池。
J Biol Chem. 1996 Jul 26;271(30):18224-30. doi: 10.1074/jbc.271.30.18224.
10
Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites.ErbB2参与了由缺乏C末端自磷酸化位点的截短型表皮生长因子受体所介导的、导致细胞周期进程的信号通路。
J Biol Chem. 1996 Apr 5;271(14):8338-44. doi: 10.1074/jbc.271.14.8338.

引用本文的文献

1
Mapping the Interactome of KRAS and Its G12C/D/V Mutants by Integrating TurboID Proximity Labeling with Quantitative Proteomics.通过整合TurboID邻近标记与定量蛋白质组学绘制KRAS及其G12C/D/V突变体的相互作用组图谱。
Biology (Basel). 2025 Apr 26;14(5):477. doi: 10.3390/biology14050477.
2
Allosteric modulation of Grb2 drives ligand-dependent signal responses.Grb2的变构调节驱动配体依赖性信号反应。
Biol Direct. 2025 May 23;20(1):63. doi: 10.1186/s13062-025-00656-5.
3
LRRC8A-containing anion channels promote glioblastoma proliferation via a WNK1/mTORC2-dependent mechanism.
含LRRC8A的阴离子通道通过WNK1/mTORC2依赖性机制促进胶质母细胞瘤增殖。
bioRxiv. 2025 Feb 6:2025.02.02.636139. doi: 10.1101/2025.02.02.636139.
4
Generating and validating renewable affimer protein binding reagents targeting SH2 domains.生成和验证针对 SH2 结构域的可再生亲和素蛋白结合试剂。
Sci Rep. 2024 Nov 16;14(1):28322. doi: 10.1038/s41598-024-79357-4.
5
An updated overview of K-RAS G12C inhibitors in advanced stage non-small cell lung cancer.晚期非小细胞肺癌中 K-RAS G12C 抑制剂的最新综述。
Future Oncol. 2024;20(37):3019-3038. doi: 10.1080/14796694.2024.2407280. Epub 2024 Oct 3.
6
Oncogenic mutations of KRAS modulate its turnover by the CUL3/LZTR1 E3 ligase complex.致癌突变的 KRAS 通过 CUL3/LZTR1 E3 连接酶复合物调节其周转率。
Life Sci Alliance. 2024 Mar 7;7(5). doi: 10.26508/lsa.202302245. Print 2024 May.
7
Role of Actin-Binding Proteins in Skeletal Myogenesis.肌动蛋白结合蛋白在骨骼肌发生中的作用。
Cells. 2023 Oct 25;12(21):2523. doi: 10.3390/cells12212523.
8
A New Dawn for Targeted Cancer Therapy: Small Molecule Covalent Binding Inhibitor Targeting K-Ras (G12C).靶向癌症治疗的新曙光:靶向K-Ras(G12C)的小分子共价结合抑制剂
Curr Med Chem. 2025;32(4):647-677. doi: 10.2174/0109298673258913231019113814.
9
Mutant HRas Signaling and Rationale for Use of Farnesyltransferase Inhibitors in Head and Neck Squamous Cell Carcinoma.突变 HRas 信号传导和法尼基转移酶抑制剂在头颈部鳞状细胞癌中应用的原理。
Target Oncol. 2023 Sep;18(5):643-655. doi: 10.1007/s11523-023-00993-3. Epub 2023 Sep 4.
10
New insights into RAS in head and neck cancer.头颈部癌症中RAS的新见解。
Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):188963. doi: 10.1016/j.bbcan.2023.188963. Epub 2023 Aug 22.